Epilepsy Foundation
Giving Philosophy
The foundation believes in empowering people living with epilepsy to live life to the full through three pillars: providing essential support and information, delivering education and training to create epilepsy-smart communities, and funding research to find better treatments and ultimately a cure. Their approach emphasizes person-centred care, self-advocacy, and community inclusion.
Tips for Applicants
Applications should demonstrate alignment with the foundation's three-pillar approach (support, education, research). The foundation values lived experience and person-centred approaches. For research funding, proposals should address their published research priorities. Organizations should highlight how programs improve quality of life, promote inclusion, or advance understanding of epilepsy.
Programs & Opportunities (3)
This grant, in collaboration with Syngap Research Fund Australia, sought Expressions of Interest (EOI) from investigators for SYNGAP-1 research, focusing on novel therapeutic approaches or clinical trial readiness projects for SYNGAP-1.
Grants for medical and psycho-social research into epilepsy including pre-clinical, translational, clinical and social/community research. Must be for organisations with DGR Item 1 and Tax Concession Charity status.
This fund supports innovative and high-quality research aimed at curing epilepsy or reducing its impact on people's lives, and finding new and improved treatments. It supports researchers, universities, research institutes, and hospitals, with applications open to organisations holding Deductible Gift Recipient (DGR) Item 1 and Tax Concession Charity (TCC) status.
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $11.1M | $11.1M | $17.9M | $62K |
| 2022 | $9.9M | $10.0M | $18.6M | $-103,112 |
| 2021 | $8.7M | $6.9M | $18.7M | $1.8M |
| 2020 | $6.5M | $6.3M | $14.6M | $178K |
| 2019 | $5.0M | $4.7M | $8.3M | $299K |
| 2018 | $4.1M | $4.0M | $6.1M | $134K |
| 2017 | $4.2M | $4.2M | $5.9M | $24K |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-75967571784
- ABN
- 75967571784
- Sector
- health
- Financial Year
- 2023
Focus Areas
Board & Leadership (8)
- ANDREW HARRINGTON MACMILLANboard member
- Catherine Marshallboard member
- Christine Walkerboard member
- Dennis Clarkboard member
- LYNNE GALLUCCIboard member
- Mark Cookboard member
- Rosanne Bellboard member
- JOSEPH AZOULAYchair
Financials
- Revenue
- $11.1M
- Assets
- $17.9M
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 23
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 3126
- Locality
- CAMBERWELL EAST
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 10/10
- LGA
- Boroondara
- SA2 Region
- Surrey Hills (West) - Canterbury
- Entities in Area
- 123
Disability Market Context
NDIS LayerThis organisation shows disability-related delivery signals. The strategic question is whether it sits inside a resilient market, a thin market, or a captured market where large providers take most of the money and local alternatives are scarce.